{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T00:27:52Z","timestamp":1789172872067,"version":"build-2803163510"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,11,15]],"date-time":"2016-11-15T00:00:00Z","timestamp":1479168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,11,15]],"date-time":"2016-11-15T00:00:00Z","timestamp":1479168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Bullous pemphigoid (BP) is an autoimmune blistering skin disease with increasing incidence. BP is associated with neurological disorders, but it has not been established, what subtypes of dementia and stroke are associated with BP, and what is the temporal relation between these diseases. Also, the association between BP and psychiatric disorders is controversial. We conducted a retrospective nationwide study, using the Finnish Care Register for Health Care diagnoses between 1987 and 2013. The study population of 4524 BP patients were compared with 66138 patients with basocellular carcinoma (BCC), neurological and psychiatric comorbid disorders were evaluated for both groups, and associations were estimated by Cox regression and logistic regression analyses. The strongest risk of developing BP was found after diagnosis of multiple sclerosis (MS) (OR=5.9, 95% CI 3.9\u20138.5). Among psychiatric diseases, the corresponding risk was strongest in schizophrenia (OR=2.7, 95% CI 2.0\u20133.5), and as a novel finding, also personality disorders (OR=2.2, 95% CI 1.3\u20133.3) preceded BP. In conclusion, many psychiatric disorders, especially schizophrenia, carry heightened risk for BP. Furthermore, several neurological diseases which cause central nervous system inflammation or degeneration were related to BP, and the association was strongest between MS and BP.<\/jats:p>","DOI":"10.1038\/srep37125","type":"journal-article","created":{"date-parts":[[2016,11,15]],"date-time":"2016-11-15T10:36:06Z","timestamp":1479206166000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":82,"title":["Psychiatric and neurological disorders are associated with bullous pemphigoid \u2013 a nationwide Finnish Care Register study"],"prefix":"10.1038","volume":"6","author":[{"given":"Anna-Kaisa","family":"F\u00f6rsti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jari","family":"Jokelainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Ansakorpi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"Sepp\u00e4nen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari","family":"Majamaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markku","family":"Timonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaisa","family":"Tasanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,11,15]]},"reference":[{"key":"BFsrep37125_CR1","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1111\/bjd.13189","volume":"171","author":"AK Forsti","year":"2014","unstructured":"Forsti, A. K., Jokelainen, J., Timonen, M. & Tasanen, K. Increasing incidence of bullous pemphigoid in Northern Finland: a retrospective database study in Oulu University Hospital. Br. J. Dermatol. 171, 1223\u20131226 (2014).","journal-title":"Br. J. Dermatol."},{"key":"BFsrep37125_CR2","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1038\/jid.2012.35","volume":"132","author":"P Joly","year":"2012","unstructured":"Joly, P. et al. Incidence and mortality of bullous pemphigoid in France. J. Invest. Dermatol. 132, 1998\u20132004 (2012).","journal-title":"J. Invest. Dermatol."},{"key":"BFsrep37125_CR3","doi-asserted-by":"publisher","first-page":"a180","DOI":"10.1136\/bmj.a180","volume":"337","author":"SM Langan","year":"2008","unstructured":"Langan, S. M. et al. Bullous pemphigoid and pemphigus vulgaris\u2013incidence and mortality in the UK: population based cohort study. BMJ 337, a180 (2008).","journal-title":"BMJ"},{"key":"BFsrep37125_CR4","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/S0140-6736(12)61140-4","volume":"381","author":"E Schmidt","year":"2013","unstructured":"Schmidt, E. & Zillikens, D. Pemphigoid diseases. Lancet 381, 320\u2013332 (2013).","journal-title":"Lancet"},{"key":"BFsrep37125_CR5","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/j.jaad.2014.07.052","volume":"71","author":"KE Brick","year":"2014","unstructured":"Brick, K. E. et al. A population-based study of the association between bullous pemphigoid and neurologic disorders. J. Am. Acad. Dermatol. 71, 1191\u20131197 (2014).","journal-title":"J. Am. Acad. Dermatol."},{"key":"BFsrep37125_CR6","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/jid.2010.357","volume":"131","author":"SM Langan","year":"2011","unstructured":"Langan, S. M., Groves, R. W. & West, J. The relationship between neurological disease and bullous pemphigoid: a population-based case-control study. J. Invest. Dermatol. 131, 631\u2013636 (2011).","journal-title":"J. Invest. Dermatol."},{"key":"BFsrep37125_CR7","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1111\/j.1365-2133.2011.10386.x","volume":"165","author":"YJ Chen","year":"2011","unstructured":"Chen, Y. J. et al. Comorbidity profiles among patients with bullous pemphigoid: a nationwide population-based study. Br. J. Dermatol. 165, 593\u2013599 (2011).","journal-title":"Br. J. Dermatol"},{"key":"BFsrep37125_CR8","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.jaad.2013.06.033","volume":"69","author":"EL Ong","year":"2013","unstructured":"Ong, E. L., Goldacre, R. & Taghipour, K. The relationship between motor neuron disease and bullous pemphigoid: an English cohort study. J. Am. Acad. Dermatol. 69, 836\u2013837 (2013).","journal-title":"J. Am. Acad. Dermatol."},{"key":"BFsrep37125_CR9","doi-asserted-by":"publisher","first-page":"240570","DOI":"10.1155\/2013\/240570","volume":"2013","author":"A Seppanen","year":"2013","unstructured":"Seppanen, A. Collagen XVII: a shared antigen in neurodermatological interactions? Clin. Dev. Immunol. 2013, 240570 (2013).","journal-title":"Clin. Dev. Immunol."},{"key":"BFsrep37125_CR10","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/exd.12877","volume":"25","author":"K Kunzli","year":"2016","unstructured":"Kunzli, K., Favre, B., Chofflon, M. & Borradori, L. One gene but different proteins and diseases: the complexity of dystonin and bullous pemphigoid antigen 1. Exp. Dermatol. 25, 10\u201316 (2016).","journal-title":"Exp. Dermatol."},{"key":"BFsrep37125_CR11","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/jid.2010.301","volume":"131","author":"S Bastuji-Garin","year":"2011","unstructured":"Bastuji-Garin, S. et al. Risk factors for bullous pemphigoid in the elderly: a prospective case-control study. J. Invest. Dermatol. 131, 637\u2013643 (2011).","journal-title":"J. Invest. Dermatol."},{"key":"BFsrep37125_CR12","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1590\/abd1806-4841.20142516","volume":"89","author":"VB Teixeira","year":"2014","unstructured":"Teixeira, V. B., Cabral, R., Brites, M. M., Vieira, R. & Figueiredo, A. Bullous pemphigoid and comorbidities: a case-control study in Portuguese patients. An. Bras. Dermatol. 89, 274\u2013278 (2014).","journal-title":"An. Bras. Dermatol"},{"key":"BFsrep37125_CR13","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1177\/1403494812456637","volume":"40","author":"R Sund","year":"2012","unstructured":"Sund, R. Quality of the Finnish Hospital Discharge Register: a systematic review. Scand. J. Public Health 40, 505\u2013515 (2012).","journal-title":"Scand. J. Public Health"},{"key":"BFsrep37125_CR14","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1177\/1352458510369146","volume":"16","author":"A Langer-Gould","year":"2010","unstructured":"Langer-Gould, A., Albers, K. B., Van Den Eeden, S. K. & Nelson, L. M. Autoimmune diseases prior to the diagnosis of multiple sclerosis: a population-based case-control study. Mult. Scler. 16, 855\u2013861 (2010).","journal-title":"Mult. Scler."},{"key":"BFsrep37125_CR15","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1161\/STROKEAHA.110.596361","volume":"42","author":"YW Yang","year":"2011","unstructured":"Yang, Y. W., Chen, Y. H., Xirasagar, S. & Lin, H. C. Increased risk of stroke in patients with bullous pemphigoid: a population-based follow-up study. Stroke 42, 319\u2013323 (2011).","journal-title":"Stroke"},{"key":"BFsrep37125_CR16","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","volume":"14","author":"MT Heneka","year":"2015","unstructured":"Heneka, M. T. et al. Neuroinflammation in Alzheimer\u2019s disease. Lancet Neurol. 14, 388\u2013405 (2015).","journal-title":"Lancet Neurol"},{"key":"BFsrep37125_CR17","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/S1474-4422(09)70062-6","volume":"8","author":"EC Hirsch","year":"2009","unstructured":"Hirsch, E. C. & Hunot, S. Neuroinflammation in Parkinson\u2019s disease: a target for neuroprotection? Lancet Neurol. 8, 382\u2013397 (2009).","journal-title":"Lancet Neurol"},{"key":"BFsrep37125_CR18","doi-asserted-by":"publisher","first-page":"372","DOI":"10.3389\/fnins.2015.00372","volume":"9","author":"N Muller","year":"2015","unstructured":"Muller, N., Weidinger, E., Leitner, B. & Schwarz, M. J. The role of inflammation in schizophrenia. Front. Neurosci. 9, 372 (2015).","journal-title":"Front. Neurosci"},{"key":"BFsrep37125_CR19","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3389\/fncel.2015.00054","volume":"9","author":"A Lourbopoulos","year":"2015","unstructured":"Lourbopoulos, A., Erturk, A. & Hellal, F. Microglia in action: how aging and injury can change the brain\u2019s guardians. Front. Cell. Neurosci. 9, 54 (2015).","journal-title":"Front. Cell. Neurosci"},{"key":"BFsrep37125_CR20","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1007\/s00213-016-4214-0","volume":"233","author":"A Bhattacharya","year":"2016","unstructured":"Bhattacharya, A., Derecki, N. C., Lovenberg, T. W. & Drevets, W. C. Role of neuro-immunological factors in the pathophysiology of mood disorders. Psychopharmacology (Berl) 233, 1623\u20131636 (2016).","journal-title":"Psychopharmacology (Berl)"},{"key":"BFsrep37125_CR21","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.biopsycho.2015.09.003","volume":"112","author":"JR Fanning","year":"2015","unstructured":"Fanning, J. R., Lee, R., Gozal, D., Coussons-Read, M. & Coccaro, E. F. Childhood trauma and parental style: Relationship with markers of inflammation, oxidative stress, and aggression in healthy and personality disordered subjects. Biol. Psychol. 112, 56\u201365 (2015).","journal-title":"Biol. Psychol."},{"key":"BFsrep37125_CR22","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1515\/hsz-2015-0257","volume":"397","author":"YM Naaldijk","year":"2016","unstructured":"Naaldijk, Y. M., Bittencourt, M. C., Sack, U. & Ulrich, H. Kinins and microglial responses in bipolar disorder: a neuroinflammation hypothesis. Biol. Chem. 397, 283\u2013296 (2016).","journal-title":"Biol. Chem"},{"key":"BFsrep37125_CR23","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jdermsci.2013.12.001","volume":"73","author":"W Nishie","year":"2014","unstructured":"Nishie, W. Update on the pathogenesis of bullous pemphigoid: an autoantibody-mediated blistering disease targeting collagen XVII. J. Dermatol. Sci. 73, 179\u2013186 (2014).","journal-title":"J. Dermatol. Sci."},{"key":"BFsrep37125_CR24","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.matbio.2005.11.004","volume":"25","author":"A Seppanen","year":"2006","unstructured":"Seppanen, A. et al. Collagen XVII is expressed in human CNS neurons. Matrix Biol. 25, 185\u2013188 (2006).","journal-title":"Matrix Biol"},{"key":"BFsrep37125_CR25","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1002\/cne.20549","volume":"487","author":"T Claudepierre","year":"2005","unstructured":"Claudepierre, T. et al. Collagen XVII and BPAG1 expression in the retina: evidence for an anchoring complex in the central nervous system. J. Comp. Neurol. 487, 190\u2013203 (2005).","journal-title":"J. Comp. Neurol."},{"key":"BFsrep37125_CR26","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/S0151-9638(06)70935-8","volume":"133","author":"N Foureur","year":"2006","unstructured":"Foureur, N. et al. Correlation between the presence of type-2 anti-pemphigoid antibodies and dementia in elderly subjects with no clinical signs of pemphigoid. Ann. Dermatol. Venereol. 133, 439\u2013443 (2006).","journal-title":"Ann. Dermatol. Venereol."},{"key":"BFsrep37125_CR27","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1111\/bjd.14538","volume":"175","author":"A Recke","year":"2016","unstructured":"Recke, A. et al. Parkinson\u2019s disease and multiple sclerosis are not associated with autoantibodies against structural proteins of the dermal-epidermal junction. Br. J. Dermatol. 175, 407\u2013409 (2016).","journal-title":"Br. J. Dermatol."},{"key":"BFsrep37125_CR28","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.jid.2015.12.005","volume":"136","author":"KA Messingham","year":"2016","unstructured":"Messingham, K. A. et al. Autoantibodies to Collagen XVII Are Present in Parkinson\u2019s Disease and Localize to Tyrosine-Hydroxylase Positive Neurons. J. Invest. Dermatol. 136, 721\u2013723 (2016).","journal-title":"J. Invest. Dermatol."},{"key":"BFsrep37125_CR29","doi-asserted-by":"crossref","unstructured":"Kokkonen, N. et al. Increased Levels of the Bullous Pemphigoid BP180 Autoantibody Are Associated with More Severe Dementia in Alzheimer\u2019s Disease. J. Invest. Dermatol. doi: 10.1016\/j.jid.2016.09.010. [Epub ahead of print] (2016).","DOI":"10.1016\/j.jid.2016.09.010"},{"key":"BFsrep37125_CR30","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s00403-014-1531-1","volume":"307","author":"E Alpsoy","year":"2015","unstructured":"Alpsoy, E., Akman-Karakas, A. & Uzun, S. Geographic variations in epidemiology of two autoimmune bullous diseases: pemphigus and bullous pemphigoid. Arch. Dermatol. Res. 307, 291\u2013298 (2015).","journal-title":"Arch. Dermatol. Res."},{"key":"BFsrep37125_CR31","doi-asserted-by":"publisher","first-page":"8569","DOI":"10.1073\/pnas.93.16.8569","volume":"93","author":"JC Delgado","year":"1996","unstructured":"Delgado, J. C. et al. A common major histocompatibility complex class II allele HLA-DQB1* 0301 is present in clinical variants of pemphigoid. Proc. Natl. Acad. Sci. USA 93, 8569\u20138571 (1996).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFsrep37125_CR32","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1111\/j.1365-2133.2009.09300.x","volume":"161","author":"G Marazza","year":"2009","unstructured":"Marazza, G. et al. Incidence of bullous pemphigoid and pemphigus in Switzerland: a 2-year prospective study. Br. J. Dermatol. 161, 861\u2013868 (2009).","journal-title":"Br. J. Dermatol"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep37125.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep37125","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep37125.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T02:40:16Z","timestamp":1672886416000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep37125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,15]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,12,23]]}},"alternative-id":["BFsrep37125"],"URL":"https:\/\/doi.org\/10.1038\/srep37125","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,15]]},"assertion":[{"value":"6 September 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"37125"}}